| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.887 | 0.006 | 0.887 | Antiinflammatory | 0.837 0.011 DBMET01479 | ||
| 0.883 | 0.004 | 0.883 | Platelet antagonist | 0.823 0.004 DBMET01479 | ||
| 0.849 | 0.005 | 0.849 | Cyclophilin D inhibitor | 0.636 0.022 DBMET01479 | ||
| 0.827 | 0.008 | 0.827 | Caspase 9 stimulant | 0.681 0.026 DBMET01479 | ||
| 0.81 | 0.004 | 0.81 | Cholesterol antagonist | 0.709 0.007 DBMET01479 | ||
| 0.74 | 0.004 | 0.74 | Hypolipemic | 0.571 0.008 DBMET01479 | ||
| 0.727 | 0.004 | 0.727 | Apoptosis antagonist | 0.492 0.021 DBMET01479 | ||
| 0.706 | 0.008 | 0.803 | Antithrombotic | 0.803 0.004 DBMET01479 | DBMET01479 | |
| 0.702 | 0.006 | 0.702 | Vasodilator, peripheral | 0.648 0.01 DBMET01479 | ||
| 0.694 | 0.002 | 0.694 | GABA C receptor agonist | 0.423 0.005 DBMET01479 | ||
| 0.683 | 0.004 | 0.774 | Platelet adhesion inhibitor | 0.774 0.003 DBMET01479 | DBMET01479 | |
| 0.677 | 0.006 | 0.677 | Caspase 3 stimulant | 0.372 0.052 DBMET01479 | ||
| 0.676 | 0.005 | 0.875 | Angiogenesis stimulant | 0.875 0.003 DBMET01479 | DBMET01479 | |
| 0.668 | 0.005 | 0.695 | Platelet aggregation inhibitor | 0.695 0.005 DBMET01479 | DBMET01479 | |
| 0.689 | 0.033 | 0.689 | Apoptosis agonist | 0.667 0.036 DBMET01479 | ||
| 0.64 | 0.006 | 0.64 | Hypoglycemic | 0.524 0.013 DBMET01479 | ||
| 0.616 | 0.005 | 0.733 | Vasodilator | 0.733 0.004 DBMET01479 | DBMET01479 | |
| 0.588 | 0.004 | 0.588 | Alpha-N-acetylglucosaminidase inhibitor | 0.403 0.009 DBMET01479 | ||
| 0.584 | 0.003 | 0.584 | Vanilloid agonist | 0.26 0.005 DBMET01479 | ||
| 0.597 | 0.032 | 0.597 | Transcription factor NF kappa B inhibitor | 0.581 0.034 DBMET01479 | ||
| 0.55 | 0.017 | 0.55 | Immunomodulator | 0.196 0.169 DBMET01479 | ||
| 0.558 | 0.026 | 0.558 | Antiobesity | |||
| 0.548 | 0.026 | 0.548 | Aldehyde oxidase inhibitor | 0.183 0.114 DBMET01479 | ||
| 0.534 | 0.019 | 0.534 | Histamine release inhibitor | 0.39 0.081 DBMET01479 | ||
| 0.516 | 0.003 | 0.516 | Succinate dehydrogenase inhibitor | 0.297 0.011 DBMET01479 | ||
| 0.513 | 0.003 | 0.513 | Porphobilinogen synthase inhibitor | 0.168 0.017 DBMET01479 | ||
| 0.512 | 0.004 | 0.512 | Tyrosine 3 hydroxylase inhibitor | 0.315 0.027 DBMET01479 | ||
| 0.514 | 0.006 | 0.514 | Non-steroidal antiinflammatory agent | 0.264 0.037 DBMET01479 | ||
| 0.513 | 0.005 | 0.513 | Phospholipase C inhibitor | 0.284 0.02 DBMET01479 | ||
| 0.523 | 0.018 | 0.523 | Antioxidant | 0.308 0.059 DBMET01479 | ||
| 0.512 | 0.013 | 0.512 | Tumour necrosis factor alpha release inhibitor | 0.346 0.039 DBMET01479 | ||
| 0.514 | 0.029 | 0.544 | Immunosuppressant | 0.544 0.022 DBMET01479 | DBMET01479 | |
| 0.508 | 0.024 | 0.508 | GABA C receptor rho-3 antagonist | 0.218 0.186 DBMET01479 | ||
| 0.485 | 0.003 | 0.485 | Ferrochelatase inhibitor | 0.276 0.01 DBMET01479 | ||
| 0.486 | 0.004 | 0.577 | Protein kinase stimulant | 0.577 0.003 DBMET01479 | DBMET01479 | |
| 0.499 | 0.019 | 0.499 | Lipoxygenase inhibitor | 0.485 0.021 DBMET01479 | ||
| 0.488 | 0.009 | 0.488 | Interleukin 2 agonist | 0.417 0.023 DBMET01479 | ||
| 0.468 | 0.004 | 0.468 | Alcohol oxidase inhibitor | 0.079 0.025 DBMET01479 | ||
| 0.468 | 0.004 | 0.468 | Insulin sensitizer | 0.283 0.02 DBMET01479 | ||
| 0.457 | 0.004 | 0.457 | Phospholipase A2 inhibitor | 0.29 0.015 DBMET01479 | ||
| 0.457 | 0.005 | 0.457 | Insulin secretagoues | 0.139 0.087 DBMET01479 | ||
| 0.458 | 0.006 | 0.458 | 5 Hydroxytryptamine uptake stimulant | 0.284 0.054 DBMET01479 | ||
| 0.474 | 0.027 | 0.474 | Spasmolytic | 0.244 0.094 DBMET01479 | ||
| 0.474 | 0.033 | 0.474 | Immunostimulant | 0.418 0.045 DBMET01479 | ||
| 0.441 | 0.002 | 0.441 | Transcription factor NF kappa B stimulant | 0.223 0.007 DBMET01479 | ||
| 0.445 | 0.008 | 0.445 | Lipid peroxidase inhibitor | 0.185 0.048 DBMET01479 | ||
| 0.441 | 0.005 | 0.441 | Aldehyde dehydrogenase inhibitor | 0.192 0.03 DBMET01479 | ||
| 0.424 | 0.003 | 0.424 | Adenylate kinase inhibitor | 0.35 0.005 DBMET01479 | ||
| 0.424 | 0.011 | 0.424 | Sodium/bile acid cotransporter inhibitor | 0.377 0.025 DBMET01479 | ||
| 0.41 | 0.004 | 0.41 | Peroxisome proliferator-activated receptor gamma agonist | 0.184 0.008 DBMET01479 | ||
| 0.409 | 0.004 | 0.409 | Gastrin inhibitor | 0.352 0.01 DBMET01479 | ||
| 0.42 | 0.016 | 0.42 | Interleukin agonist | 0.295 0.051 DBMET01479 | ||
| 0.405 | 0.004 | 0.405 | Prostaglandin antagonist | 0.333 0.005 DBMET01479 | ||
| 0.45 | 0.054 | 0.45 | 15-Lipoxygenase inhibitor | 0.3 0.132 DBMET01479 | ||
| 0.394 | 0.004 | 0.394 | Catenin beta inhibitor | 0.209 0.026 DBMET01479 | ||
| 0.391 | 0.005 | 0.391 | Cell adhesion inhibitor | 0.285 0.011 DBMET01479 | ||
| 0.398 | 0.013 | 0.398 | Hepatoprotectant | 0.296 0.031 DBMET01479 | ||
| 0.404 | 0.021 | 0.404 | DNA synthesis inhibitor | 0.316 0.039 DBMET01479 | ||
| 0.439 | 0.056 | 0.439 | 5 Hydroxytryptamine release inhibitor | 0.279 0.19 DBMET01479 | ||
| 0.386 | 0.004 | 0.386 | Triose-phosphate isomerase inhibitor | 0.245 0.007 DBMET01479 | ||
| 0.385 | 0.004 | 0.385 | Glutamate dehydrogenase inhibitor | 0.22 0.009 DBMET01479 | ||
| 0.38 | 0.005 | 0.38 | Mediator release inhibitor | 0.133 0.037 DBMET01479 | ||
| 0.376 | 0.004 | 0.376 | Prostaglandin EP2 antagonist | 0.326 0.004 DBMET01479 | ||
| 0.433 | 0.063 | 0.549 | Antibacterial | 0.549 0.029 DBMET01479 | DBMET01479 | |
| 0.37 | 0.002 | 0.37 | Fumarate hydratase inhibitor | 0.173 0.004 DBMET01479 | ||
| 0.394 | 0.026 | 0.394 | Nitric oxide antagonist | 0.235 0.056 DBMET01479 | ||
| 0.387 | 0.022 | 0.387 | Peroxidase inhibitor | 0.137 0.086 DBMET01479 | ||
| 0.383 | 0.019 | 0.383 | Anesthetic general | 0.229 0.06 DBMET01479 | ||
| 0.367 | 0.006 | 0.367 | 5-Lipoxygenase inhibitor | 0.196 0.025 DBMET01479 | ||
| 0.414 | 0.055 | 0.414 | Toll-Like receptor agonist | 0.298 0.112 DBMET01479 | ||
| 0.364 | 0.005 | 0.386 | Interleukin 4 antagonist | 0.386 0.005 DBMET01479 | DBMET01479 | |
| 0.377 | 0.019 | 0.377 | Growth hormone agonist | 0.225 0.05 DBMET01479 | ||
| 0.358 | 0.011 | 0.358 | Protein-tyrosine phosphatase inhibitor | 0.219 0.04 DBMET01479 | ||
| 0.388 | 0.048 | 0.388 | 5 Hydroxytryptamine release stimulant | 0.176 0.145 DBMET01479 | ||
| 0.368 | 0.036 | 0.397 | Interleukin antagonist | 0.397 0.031 DBMET01479 | DBMET01479 | |
| 0.364 | 0.033 | 0.364 | Superoxide dismutase inhibitor | 0.178 0.144 DBMET01479 | ||
| 0.333 | 0.003 | 0.333 | Prolactin inhibitor | 0.192 0.01 DBMET01479 | ||
| 0.343 | 0.014 | 0.343 | Monophenol monooxygenase inhibitor | 0.151 0.047 DBMET01479 | ||
| 0.331 | 0.003 | 0.356 | Prostaglandin F2 alpha antagonist | 0.356 0.003 DBMET01479 | DBMET01479 | |
| 0.34 | 0.013 | 0.34 | Bone formation stimulant | 0.288 0.019 DBMET01479 | ||
| 0.338 | 0.016 | 0.338 | DNA methyltransferase I inhibitor | 0.158 0.096 DBMET01479 | ||
| 0.324 | 0.005 | 0.324 | Phosphofructokinase-1 inhibitor | 0.311 0.005 DBMET01479 | ||
| 0.323 | 0.005 | 0.323 | Catalase inhibitor | 0.218 0.012 DBMET01479 | ||
| 0.319 | 0.002 | 0.319 | Aconitate hydratase inhibitor | 0.139 0.005 DBMET01479 | ||
| 0.312 | 0.004 | 0.312 | Glycine transporter 2 inhibitor | 0.052 0.029 DBMET01479 | ||
| 0.308 | 0.004 | 0.308 | Vanilloid 1 agonist | 0.201 0.012 DBMET01479 | ||
| 0.356 | 0.055 | 0.356 | 12-Lipoxygenase inhibitor | |||
| 0.306 | 0.006 | 0.306 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.213 0.014 DBMET01479 | ||
| 0.372 | 0.071 | 0.372 | Toll-Like receptor 7 agonist | 0.278 0.125 DBMET01479 | ||
| 0.303 | 0.004 | 0.303 | Carbamoyl phosphate synthetase inhibitor | 0.196 0.008 DBMET01479 | ||
| 0.3 | 0.004 | 0.3 | Glutamate decarboxylase inhibitor | 0.155 0.012 DBMET01479 | ||
| 0.298 | 0.005 | 0.298 | Toll-Like receptor 2 antagonist | 0.203 0.022 DBMET01479 | ||
| 0.316 | 0.024 | 0.316 | DNA methylase inhibitor | 0.188 0.087 DBMET01479 | ||
| 0.319 | 0.028 | 0.319 | RNA-directed DNA polymerase inhibitor | 0.292 0.033 DBMET01479 | ||
| 0.33 | 0.042 | 0.33 | Insulysin inhibitor | 0.204 0.15 DBMET01479 | ||
| 0.288 | 0.003 | 0.288 | Lysophosphatidic acid 2 receptor antagonist | 0.038 0.014 DBMET01479 | ||
| 0.294 | 0.01 | 0.294 | Cystathionine beta-synthase inhibitor | 0.18 0.03 DBMET01479 | ||
| 0.293 | 0.011 | 0.293 | Protein-tyrosine phosphatase 1B inhibitor | 0.171 0.038 DBMET01479 | ||
| 0.325 | 0.045 | 0.325 | Free radical scavenger | 0.165 0.128 DBMET01479 | ||
| 0.295 | 0.015 | 0.295 | Antipruritic | 0.188 0.058 DBMET01479 | ||
| 0.284 | 0.005 | 0.284 | TRPA1 agonist | 0.171 0.019 DBMET01479 | ||
| 0.275 | 0.003 | 0.275 | Arachidonic acid antagonist | 0.26 0.004 DBMET01479 | ||
| 0.317 | 0.045 | 0.317 | Transcription factor STAT3 inhibitor | |||
| 0.293 | 0.023 | 0.293 | Melanin inhibitor | 0.201 0.04 DBMET01479 | ||
| 0.281 | 0.011 | 0.281 | Cell wall synthesis inhibitor | 0.133 0.082 DBMET01479 | ||
| 0.27 | 0.003 | 0.27 | Prostaglandin agonist | 0.19 0.003 DBMET01479 | ||
| 0.28 | 0.014 | 0.28 | Alkylator | 0.158 0.043 DBMET01479 | ||
| 0.268 | 0.002 | 0.268 | Vanilloid 2 antagonist | 0.089 0.007 DBMET01479 | ||
| 0.288 | 0.023 | 0.288 | Lipocortins synthesis antagonist | 0.238 0.038 DBMET01479 | ||
| 0.313 | 0.049 | 0.313 | Transcription factor STAT inhibitor | |||
| 0.285 | 0.022 | 0.285 | Interferon gamma antagonist | 0.275 0.024 DBMET01479 | ||
| 0.263 | 0.005 | 0.473 | Potassium channel large-conductance Ca-activated activator | 0.473 0.004 DBMET01479 | DBMET01479 | |
| 0.268 | 0.015 | 0.268 | Cholesterol synthesis inhibitor | 0.185 0.031 DBMET01479 | ||
| 0.267 | 0.014 | 0.267 | DNA polymerase I inhibitor | 0.189 0.032 DBMET01479 | ||
| 0.256 | 0.004 | 0.256 | Adenylate cyclase stimulant | 0.199 0.014 DBMET01479 | ||
| 0.257 | 0.007 | 0.361 | Potassium channel (Ca-activated) activator | 0.361 0.004 DBMET01479 | DBMET01479 | |
| 0.252 | 0.004 | 0.252 | Leukotriene antagonist | 0.176 0.007 DBMET01479 | ||
| 0.25 | 0.006 | 0.25 | Cell adhesion molecule inhibitor | 0.205 0.009 DBMET01479 | ||
| 0.271 | 0.028 | 0.271 | Neurotrophic factor enhancer | 0.203 0.074 DBMET01479 | ||
| 0.247 | 0.005 | 0.247 | Thioredoxin inhibitor | 0.151 0.017 DBMET01479 | ||
| 0.246 | 0.004 | 0.246 | CDC25A inhibitor | 0.136 0.015 DBMET01479 | ||
| 0.254 | 0.013 | 0.254 | ATPase inhibitor | 0.236 0.017 DBMET01479 | ||
| 0.246 | 0.005 | 0.246 | Argininosuccinate synthase inhibitor | 0.138 0.013 DBMET01479 | ||
| 0.266 | 0.028 | 0.266 | Diuretic | 0.149 0.078 DBMET01479 | ||
| 0.239 | 0.003 | 0.239 | Acyl-CoA dehydrogenase inhibitor | 0.169 0.007 DBMET01479 | ||
| 0.242 | 0.011 | 0.242 | Microtubule formation inhibitor | 0.234 0.013 DBMET01479 | ||
| 0.237 | 0.007 | 0.237 | GABA C receptor antagonist | 0.119 0.054 DBMET01479 | ||
| 0.26 | 0.031 | 0.26 | Thrombolytic | 0.167 0.07 DBMET01479 | ||
| 0.238 | 0.014 | 0.238 | Expectorant | 0.214 0.018 DBMET01479 | ||
| 0.231 | 0.008 | 0.231 | Mucolytic | 0.212 0.011 DBMET01479 | ||
| 0.223 | 0.005 | 0.223 | Leukotriene synthesis inhibitor | 0.1 0.026 DBMET01479 | ||
| 0.226 | 0.009 | 0.226 | Photosensitizer | 0.167 0.023 DBMET01479 | ||
| 0.256 | 0.039 | 0.256 | P-glycoprotein inhibitor | |||
| 0.242 | 0.03 | 0.242 | Amylase inhibitor | 0.16 0.059 DBMET01479 | ||
| 0.219 | 0.009 | 0.219 | AMP-activated protein kinase stimulant | 0.089 0.088 DBMET01479 | ||
| 0.213 | 0.005 | 0.213 | Biliverdin reductase inhibitor | 0.131 0.012 DBMET01479 | ||
| 0.214 | 0.006 | 0.214 | Toll-Like receptor 2 agonist | 0.09 0.015 DBMET01479 | ||
| 0.211 | 0.004 | 0.211 | Peroxisome proliferator-activated receptor alpha agonist | 0.083 0.016 DBMET01479 | ||
| 0.211 | 0.004 | 0.211 | Glycine receptor agonist | 0.112 0.015 DBMET01479 | ||
| 0.206 | 0.003 | 0.206 | Ca2+-transporting ATPase inhibitor | 0.175 0.009 DBMET01479 | ||
| 0.295 | 0.092 | 0.295 | Vasodilator, coronary | 0.234 0.15 DBMET01479 | ||
| 0.21 | 0.008 | 0.21 | Caspase 3 inhibitor | |||
| 0.203 | 0.004 | 0.203 | Thromboxane antagonist | 0.134 0.005 DBMET01479 | ||
| 0.243 | 0.046 | 0.243 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.194 0.077 DBMET01479 | ||
| 0.205 | 0.009 | 0.205 | Folate antagonist | 0.148 0.023 DBMET01479 | ||
| 0.202 | 0.008 | 0.202 | Keratolytic | 0.081 0.047 DBMET01479 | ||
| 0.2 | 0.008 | 0.2 | GABA C receptor rho-1 antagonist | 0.11 0.05 DBMET01479 | ||
| 0.194 | 0.004 | 0.194 | Leukotriene B4 antagonist | 0.157 0.005 DBMET01479 | ||
| 0.192 | 0.005 | 0.192 | Sphingosine 1-phosphate receptor 4 agonist | 0.103 0.024 DBMET01479 | ||
| 0.193 | 0.005 | 0.193 | Anabolic | 0.164 0.011 DBMET01479 | ||
| 0.198 | 0.012 | 0.198 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.208 | 0.024 | 0.208 | Neurotrophic factor | |||
| 0.194 | 0.01 | 0.194 | Antimetabolite | 0.08 0.019 DBMET01479 | ||
| 0.204 | 0.02 | 0.204 | Aminopeptidase B inhibitor | 0.132 0.046 DBMET01479 | ||
| 0.192 | 0.009 | 0.192 | Electrolyte absorption antagonist | 0.095 0.065 DBMET01479 | ||
| 0.188 | 0.004 | 0.188 | Leukotriene D4 antagonist | 0.049 0.01 DBMET01479 | ||
| 0.186 | 0.003 | 0.186 | Thromboxane A2 antagonist | 0.123 0.005 DBMET01479 | ||
| 0.194 | 0.012 | 0.194 | Creatine kinase inhibitor | |||
| 0.192 | 0.01 | 0.192 | Sphingosine 1-phosphate receptor 2 antagonist | 0.125 0.086 DBMET01479 | ||
| 0.184 | 0.002 | 0.184 | Retinoid X alpha receptor agonist | 0.109 0.004 DBMET01479 | ||
| 0.183 | 0.002 | 0.183 | Lysophosphatidic acid 3 receptor antagonist | 0.106 0.004 DBMET01479 | ||
| 0.182 | 0.004 | 0.182 | Thromboxane synthase inhibitor | 0.105 0.006 DBMET01479 | ||
| 0.182 | 0.005 | 0.182 | GABA aminotransferase inhibitor | 0.108 0.022 DBMET01479 | ||
| 0.181 | 0.005 | 0.181 | Acetyl-CoA transferase inhibitor | |||
| 0.178 | 0.002 | 0.178 | Prostaglandin D2 agonist | 0.118 0.003 DBMET01479 | ||
| 0.203 | 0.027 | 0.203 | GABA C receptor rho-2 antagonist | 0.126 0.114 DBMET01479 | ||
| 0.179 | 0.006 | 0.179 | Ornithine decarboxylase inhibitor | 0.135 0.017 DBMET01479 | ||
| 0.235 | 0.064 | 0.235 | Psychostimulant | |||
| 0.169 | 0.002 | 0.169 | Glucose-6-phosphate isomerase inhibitor | 0.121 0.003 DBMET01479 | ||
| 0.174 | 0.011 | 0.174 | Toll-Like receptor 4 antagonist | 0.131 0.034 DBMET01479 | ||
| 0.198 | 0.036 | 0.198 | Hexokinase inhibitor | 0.127 0.108 DBMET01479 | ||
| 0.163 | 0.003 | 0.163 | Prostaglandin E2 agonist | 0.074 0.004 DBMET01479 | ||
| 0.186 | 0.026 | 0.186 | Farnesoid X receptor antagonist | 0.166 0.037 DBMET01479 | ||
| 0.163 | 0.004 | 0.163 | Kainate receptor antagonist | |||
| 0.195 | 0.037 | 0.195 | Neurotensin receptor agonist | |||
| 0.166 | 0.01 | 0.166 | Phenylalanine 4-hydroxylase inhibitor | 0.097 0.027 DBMET01479 | ||
| 0.226 | 0.07 | 0.303 | Peptidyltransferase inhibitor | 0.303 0.024 DBMET01479 | DBMET01479 | |
| 0.164 | 0.01 | 0.164 | Aminopeptidase I inhibitor | 0.107 0.024 DBMET01479 | ||
| 0.156 | 0.002 | 0.156 | G-protein-coupled receptor 120 agonist | 0.044 0.004 DBMET01479 | ||
| 0.157 | 0.004 | 0.157 | Glutamate (mGluR6) antagonist | 0.093 0.014 DBMET01479 | ||
| 0.158 | 0.005 | 0.158 | CDC25B inhibitor | 0.059 0.052 DBMET01479 | ||
| 0.221 | 0.07 | 0.221 | Anticonvulsant | |||
| 0.154 | 0.003 | 0.154 | Retinoid X receptor agonist | 0.094 0.005 DBMET01479 | ||
| 0.178 | 0.029 | 0.178 | Cyclooxygenase 3 inhibitor | 0.134 0.063 DBMET01479 | ||
| 0.16 | 0.015 | 0.16 | NADH dehydrogenase inhibitor | 0.111 0.034 DBMET01479 | ||
| 0.166 | 0.022 | 0.166 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.16 | 0.016 | 0.178 | Selectin antagonist | 0.178 0.014 DBMET01479 | DBMET01479 | |
| 0.146 | 0.003 | 0.146 | Leukotriene C antagonist | 0.102 0.004 DBMET01479 | ||
| 0.146 | 0.003 | 0.146 | Vanilloid 4 agonist | 0.096 0.02 DBMET01479 | ||
| 0.149 | 0.008 | 0.149 | Glycine receptor antagonist | 0.1 0.033 DBMET01479 | ||
| 0.16 | 0.018 | 0.16 | Alcohol dehydrogenase inhibitor | |||
| 0.148 | 0.007 | 0.148 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.098 0.017 DBMET01479 | ||
| 0.186 | 0.048 | 0.186 | Cyclooxygenase inhibitor | |||
| 0.147 | 0.008 | 0.167 | ATPase (Vacuolar H+) inhibitor | 0.167 0.005 DBMET01479 | DBMET01479 | |
| 0.148 | 0.01 | 0.148 | Ornithine carbamoyltransferase inhibitor | 0.073 0.024 DBMET01479 | ||
| 0.137 | 0.002 | 0.137 | Membrane dipeptidase inhibitor | 0.074 0.006 DBMET01479 | ||
| 0.144 | 0.009 | 0.144 | NMDA receptor agonist | |||
| 0.178 | 0.044 | 0.178 | Cyclooxygenase 1 inhibitor | |||
| 0.156 | 0.022 | 0.156 | Sphingomyelinase inhibitor | 0.109 0.05 DBMET01479 | ||
| 0.156 | 0.023 | 0.156 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.138 | 0.005 | 0.138 | Sphingosine 1-phosphate receptor 5 agonist | 0.066 0.019 DBMET01479 | ||
| 0.138 | 0.007 | 0.138 | Peroxisome proliferator-activated receptor gamma antagonist | 0.093 0.02 DBMET01479 | ||
| 0.135 | 0.004 | 0.135 | Peroxisome proliferator-activated receptor alpha antagonist | 0.031 0.011 DBMET01479 | ||
| 0.153 | 0.022 | 0.153 | Calcium antagonist | |||
| 0.175 | 0.046 | 0.175 | Hemostatic | 0.151 0.066 DBMET01479 | ||
| 0.143 | 0.014 | 0.143 | Lanosterol 14 alpha demethylase inhibitor | 0.094 0.066 DBMET01479 | ||
| 0.15 | 0.021 | 0.15 | DOPA decarboxylase inhibitor | 0.097 0.082 DBMET01479 | ||
| 0.132 | 0.004 | 0.132 | Prostaglandin D2 antagonist | 0.107 0.005 DBMET01479 | ||
| 0.13 | 0.002 | 0.13 | Kainate receptor agonist | 0.076 0.004 DBMET01479 | ||
| 0.14 | 0.013 | 0.14 | Ribonucleoside-diphosphate reductase inhibitor | 0.067 0.03 DBMET01479 | ||
| 0.317 | 0.191 | 0.317 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.131 | 0.005 | 0.131 | Prostaglandin EP3 antagonist | 0.101 0.005 DBMET01479 | ||
| 0.131 | 0.005 | 0.131 | Oleamide hydrolase inhibitor | |||
| 0.153 | 0.028 | 0.153 | UDP-glucose 4-epimerase inhibitor | 0.109 0.052 DBMET01479 | ||
| 0.26 | 0.135 | 0.26 | Calcium channel activator | |||
| 0.152 | 0.028 | 0.152 | Carbonic anhydrase III inhibitor | 0.09 0.075 DBMET01479 | ||
| 0.179 | 0.055 | 0.494 | Interleukin 6 antagonist | 0.494 0.005 DBMET01479 | DBMET01479 | |
| 0.128 | 0.005 | 0.128 | Phospholipase D inhibitor | 0.065 0.064 DBMET01479 | ||
| 0.126 | 0.003 | 0.126 | Prostacyclin agonist | 0.082 0.004 DBMET01479 | ||
| 0.155 | 0.033 | 0.155 | GABA receptor agonist | |||
| 0.136 | 0.014 | 0.136 | Ribonucleotide reductase inhibitor | 0.068 0.032 DBMET01479 | ||
| 0.142 | 0.021 | 0.142 | Histidine decarboxylase inhibitor | |||
| 0.16 | 0.039 | 0.16 | Cathepsin H inhibitor | 0.114 0.084 DBMET01479 | ||
| 0.124 | 0.006 | 0.124 | GABA B receptor agonist | 0.071 0.064 DBMET01479 | ||
| 0.121 | 0.003 | 0.121 | Prostaglandin EP4 agonist | 0.081 0.004 DBMET01479 | ||
| 0.119 | 0.002 | 0.119 | Leukotriene C4 antagonist | 0.076 0.004 DBMET01479 | ||
| 0.144 | 0.029 | 0.144 | Gastric antisecretory | |||
| 0.118 | 0.004 | 0.118 | Kainate receptor 2 antagonist | |||
| 0.119 | 0.005 | 0.119 | Peroxisome proliferator-activated receptor delta agonist | 0.035 0.022 DBMET01479 | ||
| 0.128 | 0.014 | 0.128 | Bile acid receptor antagonist | 0.107 0.036 DBMET01479 | ||
| 0.153 | 0.039 | 0.153 | Heat shock protein 70 antagonist | |||
| 0.126 | 0.015 | 0.126 | Interferon agonist | 0.091 0.038 DBMET01479 | ||
| 0.154 | 0.043 | 0.154 | Antibacterial (Helicobacter pylori) | 0.123 0.076 DBMET01479 | ||
| 0.125 | 0.019 | 0.125 | Glutamate release inhibitor | |||
| 0.119 | 0.015 | 0.126 | Cannabinoid CB1 receptor agonist | 0.126 0.013 DBMET01479 | DBMET01479 | |
| 0.115 | 0.012 | 0.115 | Estrogen-related receptor beta agonist | 0.082 0.06 DBMET01479 | ||
| 0.123 | 0.021 | 0.123 | Glutathione S-transferase inhibitor | |||
| 0.128 | 0.029 | 0.128 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.116 | 0.017 | 0.116 | Amidase inhibitor | |||
| 0.106 | 0.009 | 0.106 | Fatty acid synthase inhibitor | |||
| 0.101 | 0.004 | 0.101 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.039 0.017 DBMET01479 | ||
| 0.115 | 0.019 | 0.115 | Na+ K+ transporting ATPase inhibitor | 0.1 0.032 DBMET01479 | ||
| 0.096 | 0.002 | 0.096 | Prostaglandin F2 alpha agonist | 0.089 0.002 DBMET01479 | ||
| 0.095 | 0.002 | 0.095 | Lysophosphatidic acid 1 receptor antagonist | 0.034 0.005 DBMET01479 | ||
| 0.097 | 0.005 | 0.097 | Prostaglandin EP4 antagonist | 0.049 0.008 DBMET01479 | ||
| 0.094 | 0.003 | 0.094 | Prostaglandin EP2 agonist | 0.07 0.004 DBMET01479 | ||
| 0.094 | 0.004 | 0.094 | Kainate receptor 1 antagonist | |||
| 0.095 | 0.005 | 0.095 | Prostacyclin antagonist | 0.076 0.006 DBMET01479 | ||
| 0.094 | 0.004 | 0.094 | Pregnane X receptor antagonist | 0.081 0.006 DBMET01479 | ||
| 0.119 | 0.03 | 0.119 | Topoisomerase II alpha inhibitor | |||
| 0.102 | 0.013 | 0.102 | Caspase 9 inhibitor | 0.065 0.039 DBMET01479 | ||
| 0.095 | 0.007 | 0.095 | Squalene synthetase inhibitor | 0.057 0.012 DBMET01479 | ||
| 0.092 | 0.003 | 0.092 | Glutamate (mGluR8) agonist | 0.055 0.009 DBMET01479 | ||
| 0.092 | 0.004 | 0.092 | Leukotriene B4 receptor 1 antagonist | 0.048 0.008 DBMET01479 | ||
| 0.092 | 0.005 | 0.092 | Acetyl-CoA transferase 1 inhibitor | |||
| 0.11 | 0.023 | 0.11 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.089 | 0.002 | 0.089 | Lysophosphatidic acid receptor 1 agonist | 0.056 0.003 DBMET01479 | ||
| 0.09 | 0.004 | 0.09 | GABA uptake inhibitor | 0.038 0.029 DBMET01479 | ||
| 0.125 | 0.04 | 0.157 | Electron transport complex I inhibitor | 0.157 0.017 DBMET01479 | DBMET01479 | |
| 0.089 | 0.004 | 0.089 | Free fatty acid receptor 1 agonist | 0.018 0.012 DBMET01479 | ||
| 0.095 | 0.011 | 0.095 | Exportin-1 inhibitor | 0.074 0.034 DBMET01479 | ||
| 0.099 | 0.017 | 0.099 | Purinergic P2X1 antagonist | 0.056 0.05 DBMET01479 | ||
| 0.11 | 0.03 | 0.11 | Cathepsin G inhibitor | |||
| 0.151 | 0.071 | 0.151 | NOS3 expression enhancer | |||
| 0.094 | 0.015 | 0.094 | Interferon inducer | 0.069 0.036 DBMET01479 | ||
| 0.188 | 0.111 | 0.188 | Nitric-oxide synthase stimulant | 0.183 0.122 DBMET01479 | ||
| 0.126 | 0.05 | 0.126 | Transcription factor STAT6 inhibitor | |||
| 0.143 | 0.067 | 0.143 | Pregnane X receptor agonist | |||
| 0.173 | 0.098 | 0.173 | Growth factor agonist | |||
| 0.089 | 0.017 | 0.089 | Prostaglandin E2 antagonist | 0.051 0.035 DBMET01479 | ||
| 0.113 | 0.041 | 0.227 | Antineoplastic antibiotic | 0.227 0.017 DBMET01479 | DBMET01479 | |
| 0.1 | 0.029 | 0.1 | Thioredoxin reductase inhibitor | |||
| 0.094 | 0.024 | 0.094 | Elastase 1 inhibitor | |||
| 0.086 | 0.017 | 0.086 | Nitric oxide donor | 0.075 0.027 DBMET01479 | ||
| 0.073 | 0.004 | 0.073 | ATP citrate lysase inhibitor | 0.042 0.012 DBMET01479 | ||
| 0.069 | 0.002 | 0.069 | Thromboxane agonist | 0.036 0.003 DBMET01479 | ||
| 0.083 | 0.016 | 0.083 | MDM2 inhibitor | 0.069 0.042 DBMET01479 | ||
| 0.068 | 0.002 | 0.068 | Lysophosphatidic acid receptor 3 agonist | 0.043 0.003 DBMET01479 | ||
| 0.075 | 0.009 | 0.075 | G protein-coupled receptor agonist | |||
| 0.07 | 0.004 | 0.07 | Retinoid X receptor antagonist | 0.049 0.013 DBMET01479 | ||
| 0.079 | 0.014 | 0.079 | Lipocortins synthesis agonist | 0.064 0.028 DBMET01479 | ||
| 0.084 | 0.019 | 0.084 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.059 0.036 DBMET01479 | ||
| 0.131 | 0.069 | 0.131 | Cyclooxygenase 2 inhibitor | |||
| 0.101 | 0.039 | 0.101 | Carbonic anhydrase VI inhibitor | |||
| 0.084 | 0.023 | 0.084 | Glutamate (mGluR7) antagonist | |||
| 0.065 | 0.004 | 0.065 | Leukotriene B4 receptor 2 antagonist | 0.032 0.008 DBMET01479 | ||
| 0.116 | 0.057 | 0.116 | Chelator | |||
| 0.105 | 0.046 | 0.105 | Interleukin 12 antagonist | |||
| 0.064 | 0.004 | 0.064 | Vanilloid 3 antagonist | |||
| 0.063 | 0.004 | 0.063 | HMG CoA reductase inhibitor | 0.051 0.007 DBMET01479 | ||
| 0.072 | 0.014 | 0.072 | CD45 antagonist | |||
| 0.067 | 0.009 | 0.067 | Geranyltranstransferase inhibitor | |||
| 0.076 | 0.019 | 0.076 | Sphingosine kinase inhibitor | |||
| 0.204 | 0.147 | 0.204 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.07 | 0.013 | 0.07 | Adenosine deaminase inhibitor | 0.055 0.026 DBMET01479 | ||
| 0.087 | 0.03 | 0.087 | Glucagon-like peptide 1 agonist | |||
| 0.071 | 0.014 | 0.071 | HCV NS3/NS4A protease inhibitor | 0.05 0.032 DBMET01479 | ||
| 0.083 | 0.026 | 0.083 | NMDA receptor glycine site agonist | |||
| 0.081 | 0.025 | 0.081 | Carbonic anhydrase stimulant | |||
| 0.174 | 0.118 | 0.174 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.103 | 0.047 | 0.103 | Phosphodiesterase 6D inhibitor | |||
| 0.064 | 0.009 | 0.064 | Arginase inhibitor | 0.034 0.028 DBMET01479 | ||
| 0.119 | 0.063 | 0.119 | Interleukin 8 antagonist | |||
| 0.067 | 0.013 | 0.067 | Mannosidase inhibitor | 0.047 0.029 DBMET01479 | ||
| 0.094 | 0.04 | 0.094 | mTOR complex 2 inhibitor | |||
| 0.071 | 0.016 | 0.071 | Alpha-mannosidase inhibitor | 0.054 0.036 DBMET01479 | ||
| 0.058 | 0.004 | 0.058 | Retinoid X alpha receptor antagonist | 0.041 0.014 DBMET01479 | ||
| 0.095 | 0.042 | 0.095 | Hematopoietic | |||
| 0.055 | 0.002 | 0.055 | Thromboxane A2 agonist | 0.038 0.003 DBMET01479 | ||
| 0.063 | 0.01 | 0.063 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.056 | 0.003 | 0.056 | Prostaglandin H2 antagonist | 0.044 0.005 DBMET01479 | ||
| 0.064 | 0.012 | 0.064 | AICAR transformylase inhibitor | 0.045 0.028 DBMET01479 | ||
| 0.073 | 0.022 | 0.073 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.068 | 0.019 | 0.068 | Plasminogen activator inhibitor antagonist | |||
| 0.052 | 0.003 | 0.052 | Carbonic anhydrase X inhibitor | 0.019 0.009 DBMET01479 | ||
| 0.052 | 0.003 | 0.052 | Carbonic anhydrase VIII inhibitor | 0.019 0.009 DBMET01479 | ||
| 0.053 | 0.004 | 0.053 | Glutamate (mGluR3) agonist | 0.034 0.019 DBMET01479 | ||
| 0.06 | 0.013 | 0.06 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.189 | 0.141 | 0.189 | Neuropeptide Y2 antagonist | |||
| 0.053 | 0.006 | 0.053 | Integrin alpha1beta1 antagonist | 0.037 0.032 DBMET01479 | ||
| 0.067 | 0.02 | 0.067 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.054 | 0.007 | 0.054 | Glutamate (mGluR8) antagonist | 0.038 0.021 DBMET01479 | ||
| 0.135 | 0.088 | 0.135 | Thiol protease inhibitor | |||
| 0.062 | 0.016 | 0.062 | Thymidylate synthase inhibitor | |||
| 0.165 | 0.12 | 0.165 | Histone acetyltransferase inhibitor | |||
| 0.059 | 0.014 | 0.059 | Glutamate (mGluR4) antagonist | |||
| 0.115 | 0.07 | 0.115 | Proteasome inhibitor | |||
| 0.061 | 0.016 | 0.061 | Sphingosine 1-phosphate receptor agonist | |||
| 0.054 | 0.01 | 0.054 | Glutamate (mGluR3) antagonist | |||
| 0.059 | 0.015 | 0.059 | Microtubule stabilization | 0.049 0.03 DBMET01479 | ||
| 0.079 | 0.036 | 0.079 | Potassium channel (Tandem pore domain) blocker | |||
| 0.051 | 0.007 | 0.051 | Lysine carboxypeptidase inhibitor | |||
| 0.088 | 0.045 | 0.088 | Carbonic anhydrase XIII inhibitor | |||
| 0.047 | 0.005 | 0.047 | Calcium-independent phospholipase A2 inhibitor | 0.038 0.014 DBMET01479 | ||
| 0.051 | 0.009 | 0.051 | Free fatty acid receptor 1 antagonist | |||
| 0.045 | 0.003 | 0.045 | Retinoid X beta receptor antagonist | 0.028 0.005 DBMET01479 | ||
| 0.049 | 0.007 | 0.049 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.055 | 0.013 | 0.055 | Nicotinic acid receptor agonist | |||
| 0.047 | 0.005 | 0.047 | Glutamate (mGluR1a) agonist | |||
| 0.082 | 0.04 | 0.082 | Lipase inhibitor | |||
| 0.058 | 0.016 | 0.058 | 5-Alpha-reductase inhibitor | |||
| 0.067 | 0.025 | 0.067 | Cannabinoid CB2 receptor antagonist | |||
| 0.1 | 0.059 | 0.1 | Glutamate (mGluR7) agonist | |||
| 0.046 | 0.005 | 0.046 | Elastase 3A inhibitor | 0.033 0.017 DBMET01479 | ||
| 0.046 | 0.005 | 0.046 | Elastase 2B inhibitor | 0.033 0.017 DBMET01479 | ||
| 0.046 | 0.005 | 0.046 | Elastase 3B inhibitor | 0.033 0.017 DBMET01479 | ||
| 0.073 | 0.033 | 0.073 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.065 | 0.026 | 0.065 | GP IIb/IIIa receptor antagonist | |||
| 0.12 | 0.081 | 0.12 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.081 | 0.044 | 0.081 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.051 | 0.014 | 0.051 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.063 | 0.026 | 0.063 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.051 | 0.014 | 0.051 | AMPA 4 receptor antagonist | |||
| 0.053 | 0.018 | 0.053 | Glutamate (mGluR group III) antagonist | |||
| 0.05 | 0.014 | 0.05 | Farnesoid X receptor agonist | |||
| 0.097 | 0.062 | 0.097 | Xanthine oxidase inhibitor | |||
| 0.069 | 0.034 | 0.069 | TRPA1 antagonist | |||
| 0.063 | 0.028 | 0.063 | Sphingosine kinase 2 inhibitor | |||
| 0.11 | 0.076 | 0.11 | Adenylate cyclase inhibitor | |||
| 0.041 | 0.007 | 0.041 | Retinoid X gamma receptor agonist | 0.035 0.009 DBMET01479 | ||
| 0.063 | 0.029 | 0.063 | Ryanodine receptor antagonist | |||
| 0.058 | 0.026 | 0.058 | Heparanase inhibitor | |||
| 0.077 | 0.045 | 0.077 | Epoxide hydrolase inhibitor | |||
| 0.037 | 0.005 | 0.037 | Retinoid X gamma receptor antagonist | 0.034 0.008 DBMET01479 | ||
| 0.068 | 0.036 | 0.068 | Cannabinoid CB1 receptor antagonist | |||
| 0.037 | 0.006 | 0.037 | Glutamate (mGluR1) agonist | |||
| 0.063 | 0.033 | 0.063 | Maillard reaction inhibitor | |||
| 0.041 | 0.011 | 0.041 | Uridine phosphorylase inhibitor | 0.024 0.023 DBMET01479 | ||
| 0.049 | 0.019 | 0.049 | Dopamine D5 agonist | |||
| 0.036 | 0.007 | 0.036 | Retinoid X beta receptor agonist | 0.031 0.008 DBMET01479 | ||
| 0.047 | 0.018 | 0.047 | Factor XIIIa inhibitor | 0.033 0.031 DBMET01479 | ||
| 0.092 | 0.062 | 0.092 | ABCA1 expression enhancer | |||
| 0.049 | 0.02 | 0.049 | Angiotensin AT1 receptor antagonist | |||
| 0.05 | 0.021 | 0.05 | Guanylate cyclase inhibitor | |||
| 0.044 | 0.016 | 0.044 | VCAM-1 antagonist | |||
| 0.044 | 0.016 | 0.044 | VCAM antagonist | |||
| 0.055 | 0.027 | 0.055 | Squalene epoxidase inhibitor | |||
| 0.034 | 0.006 | 0.034 | Vanilloid 2 agonist | 0.024 0.022 DBMET01479 | ||
| 0.031 | 0.004 | 0.031 | Vitamin D receptor agonist | 0.019 0.008 DBMET01479 | ||
| 0.041 | 0.014 | 0.041 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.058 | 0.033 | 0.058 | Dihydroorotate oxidase inhibitor | |||
| 0.122 | 0.097 | 0.122 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.028 | 0.003 | 0.028 | Glutamate (mGluR6) agonist | 0.011 0.01 DBMET01479 | ||
| 0.04 | 0.016 | 0.04 | Caspase 2 inhibitor | |||
| 0.17 | 0.146 | 0.17 | DNA damaging | |||
| 0.083 | 0.059 | 0.083 | D-Ala-D-Ala ligase inhibitor | |||
| 0.055 | 0.033 | 0.055 | Autotaxin inhibitor | |||
| 0.063 | 0.041 | 0.063 | NMDA 2C receptor antagonist | |||
| 0.041 | 0.019 | 0.041 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.039 0.021 DBMET01479 | ||
| 0.093 | 0.071 | 0.093 | Nitric-oxide synthase inhibitor | |||
| 0.045 | 0.023 | 0.045 | Sphingosine kinase 1 inhibitor | |||
| 0.051 | 0.029 | 0.051 | Cholesterol esterase inhibitor | |||
| 0.032 | 0.011 | 0.032 | Nicotinic acid receptor 2 antagonist | |||
| 0.046 | 0.025 | 0.046 | GABA B receptor antagonist | |||
| 0.042 | 0.021 | 0.042 | Cholecystokinin B agonist | |||
| 0.037 | 0.016 | 0.037 | Carboxypeptidase B inhibitor | |||
| 0.028 | 0.007 | 0.032 | Isoleucine-tRNA ligase inhibitor | 0.032 0.004 DBMET01479 | DBMET01479 | |
| 0.03 | 0.01 | 0.03 | Prostaglandin EP1 antagonist | 0.02 0.014 DBMET01479 | ||
| 0.025 | 0.004 | 0.025 | Methylmalonyl-CoA mutase inhibitor | 0.021 0.007 DBMET01479 | ||
| 0.132 | 0.112 | 0.132 | CF transmembrane conductance regulator agonist | |||
| 0.031 | 0.011 | 0.031 | Thyroid hormone agonist | |||
| 0.106 | 0.086 | 0.106 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.055 | 0.036 | 0.055 | DNA helicase inhibitor | |||
| 0.047 | 0.028 | 0.047 | Integrin antagonist | |||
| 0.069 | 0.05 | 0.069 | Cannabinoid receptor antagonist | |||
| 0.042 | 0.024 | 0.042 | Dihydropteroate synthase inhibitor | |||
| 0.023 | 0.006 | 0.023 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | |||
| 0.156 | 0.139 | 0.156 | Antiamyloidogenic | |||
| 0.045 | 0.028 | 0.045 | Macrophage elastase inhibitor | |||
| 0.025 | 0.008 | 0.025 | Neuraminidase (Influenza B) inhibitor | 0.021 0.013 DBMET01479 | ||
| 0.041 | 0.024 | 0.041 | Retinoic acid alpha receptor agonist | 0.038 0.029 DBMET01479 | ||
| 0.038 | 0.021 | 0.038 | Phosphoglycerate kinase inhibitor | |||
| 0.036 | 0.02 | 0.036 | Angiotensin II receptor antagonist | |||
| 0.096 | 0.079 | 0.096 | Factor V inhibitor | |||
| 0.024 | 0.008 | 0.024 | Aminopeptidase A inhibitor | |||
| 0.051 | 0.035 | 0.051 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.046 | 0.03 | 0.046 | Purinergic P2Y antagonist | |||
| 0.054 | 0.038 | 0.054 | Angiotensin-converting enzyme inhibitor | |||
| 0.097 | 0.081 | 0.097 | Nav1.4 sodium channel blocker | |||
| 0.037 | 0.021 | 0.037 | Calcitonin receptor agonist | |||
| 0.041 | 0.025 | 0.041 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.055 | 0.04 | 0.055 | Carbonic anhydrase VB inhibitor | |||
| 0.073 | 0.058 | 0.073 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.04 | 0.025 | 0.04 | Urate transporter 1 inhibitor | |||
| 0.132 | 0.117 | 0.132 | Dual specificity phosphatase inhibitor | |||
| 0.023 | 0.009 | 0.023 | Caspase 8 inhibitor | |||
| 0.052 | 0.037 | 0.052 | Aldose reductase inhibitor | |||
| 0.071 | 0.057 | 0.071 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.021 | 0.007 | 0.021 | Telomerase stimulant | |||
| 0.043 | 0.03 | 0.043 | Leukocyte elastase inhibitor | |||
| 0.052 | 0.039 | 0.052 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.018 | 0.005 | 0.018 | Carbonic anhydrase XI inhibitor | |||
| 0.027 | 0.014 | 0.027 | Purinergic P2Y12 antagonist | |||
| 0.018 | 0.005 | 0.018 | Calcium-dependent phospholipase A2 inhibitor | |||
| 0.065 | 0.052 | 0.065 | Carbonic anhydrase VA inhibitor | |||
| 0.054 | 0.042 | 0.054 | Adenine nucleotide translocase inhibitor | |||
| 0.049 | 0.037 | 0.049 | Prolyl endopeptidase inhibitor | |||
| 0.038 | 0.026 | 0.038 | Leukotriene A4 hydrolase inhibitor | |||
| 0.023 | 0.011 | 0.023 | 5-Alpha-reductase 2 inhibitor | |||
| 0.016 | 0.004 | 0.016 | Calcineurin inhibitor | 0.015 0.005 DBMET01479 | ||
| 0.046 | 0.035 | 0.046 | Glycine transporter inhibitor | |||
| 0.029 | 0.018 | 0.029 | LFA antagonist | |||
| 0.047 | 0.038 | 0.047 | Bombesin 2 receptor antagonist | |||
| 0.019 | 0.01 | 0.019 | Ileal bile acid transport inhibitor | |||
| 0.03 | 0.021 | 0.03 | Peptide deformylase inhibitor | |||
| 0.065 | 0.056 | 0.065 | HIV-1 integrase inhibitor | |||
| 0.023 | 0.015 | 0.023 | ICAM 1 antagonist | |||
| 0.014 | 0.005 | 0.014 | Immunosuppressant Cyclosporine-like | 0.013 0.007 DBMET01479 | ||
| 0.022 | 0.014 | 0.022 | Integrin alphaVbeta3 antagonist | |||
| 0.036 | 0.028 | 0.036 | NMDA receptor subunit 3A antagonist | |||
| 0.04 | 0.032 | 0.04 | Oxytocin agonist | |||
| 0.088 | 0.081 | 0.088 | Topoisomerase I inhibitor | |||
| 0.03 | 0.023 | 0.03 | Epoxide hydrolase 1 inhibitor | |||
| 0.12 | 0.113 | 0.12 | Anticoagulant | |||
| 0.027 | 0.02 | 0.027 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.035 | 0.028 | 0.035 | Histone deacetylase 7 inhibitor | |||
| 0.041 | 0.034 | 0.041 | NMDA receptor subunit 3B antagonist | |||
| 0.015 | 0.008 | 0.015 | Integrin beta6 antagonist | |||
| 0.028 | 0.022 | 0.028 | AMPA 3 receptor antagonist | |||
| 0.03 | 0.025 | 0.03 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.026 | 0.021 | 0.026 | Toll-Like receptor 4 agonist | |||
| 0.017 | 0.012 | 0.017 | 5-Alpha-reductase 1 inhibitor | |||
| 0.025 | 0.021 | 0.025 | Urotensin II agonist | |||
| 0.056 | 0.052 | 0.056 | Cannabinoid receptor agonist | |||
| 0.027 | 0.023 | 0.027 | Purinergic P2Y15 antagonist | |||
| 0.041 | 0.037 | 0.041 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.03 | 0.027 | 0.03 | Sphingosine 1-phosphate receptor 3 agonist | |||
| 0.021 | 0.017 | 0.021 | Geranylgeranyltransferase inhibitor | |||
| 0.013 | 0.01 | 0.013 | Angiotensin AT1B receptor antagonist | |||
| 0.021 | 0.018 | 0.021 | Retinoic acid gamma receptor agonist | |||
| 0.008 | 0.005 | 0.008 | Phosphoribosylglycinamide formyltransferase inhibitor | |||
| 0.027 | 0.024 | 0.027 | Glucagon receptor antagonist | |||
| 0.046 | 0.044 | 0.082 | Potassium channel (Inward rectifier) activator | 0.082 0.007 DBMET01479 | DBMET01479 | |
| 0.037 | 0.035 | 0.037 | Thymidine kinase inhibitor | |||
| 0.044 | 0.042 | 0.079 | Potassium channel (ATP-sensitive) activator | 0.079 0.007 DBMET01479 | DBMET01479 | |
| 0.075 | 0.073 | 0.114 | Antineoplastic alkaloid | 0.114 0.04 DBMET01479 | DBMET01479 | |
| 0.026 | 0.024 | 0.026 | Hedgehog signaling activator | |||
| 0.028 | 0.027 | 0.028 | Caspase 6 inhibitor | |||
| 0.058 | 0.057 | 0.058 | Carbonic anhydrase V inhibitor | |||
| 0.025 | 0.024 | 0.025 | Liver X receptor beta antagonist | |||
| 0.006 | 0.005 | 0.006 | Integrin alpha5beta6 antagonist | |||
| 0.075 | 0.074 | 0.075 | Caspase 7 inhibitor | |||
| 0.076 | 0.084 | 0.112 | Potassium channel activator | 0.112 0.037 DBMET01479 | DBMET01479 | |
| 0.039 | 0.055 | 0.103 | Protein 50S ribosomal subunit inhibitor | 0.103 0.012 DBMET01479 | DBMET01479 | |
| 0.094 | 0.113 | 0.103 | Estrogen antagonist | 0.103 0.09 DBMET01479 | DBMET01479 | |
| 0.003 | 0.043 | 0.014 | Antibiotic Macrolide-like | 0.014 0.01 DBMET01479 | DBMET01479 | |
| 0.167 | 0.213 | 0.752 | Angiogenesis inhibitor | 0.752 0.006 DBMET01479 | DBMET01479 | |
| 0.01 | 0.115 | 0.073 | Glucocorticoid antagonist | 0.073 0.008 DBMET01479 | DBMET01479 | |
| 0.015 | 0.133 | 0.042 | HIV-1 protease inhibitor | 0.042 0.032 DBMET01479 | DBMET01479 | |
| 0.038 | 0.254 | 0.136 | Aminoacyl-tRNA synthetase inhibitor | 0.136 0.023 DBMET01479 | DBMET01479 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |